Janssen Cilag, through the endowment of the Paul Ehrlich Award, wishes to encourage the scientific world to work towards innovation in the fields of therapeutic research for the well-being of patients and their families, as Dr Paul Janssen, founder of Janssen-Pharmaceutica, always wanted. Dr Paul Janssen's main goal was to build on innovation and basic research in order to offer new and innovative medicines to patients, with a real impact on their quality of life. This same ambition continues to be the motivation for Janssen companies around the world.
The Jury is composed of 6 members:
The Jury is chaired by the President of the SCT.
Paul Ehrlich Award Recipients: